This HTML5 document contains 201 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9https://w3id.org/oc/corpus/br/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://dx.doi.org/10.1038/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q29615392
rdf:type
wikibase:Item
schema:description
2012年論文 scienca artikolo научни чланак 2012 nî lūn-bûn artigo científico наукова стаття, опублікована в грудні 2012 article científic 2012年论文 ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ teaduslik artikkel wissenschaftlicher Artikel artículu científicu espublizáu en 2012 2012年論文 artikull shkencor научна статия article scientific 2012年论文 επιστημονικό άρθρο 2012年の論文 artigo científico article scientifique naučni članak 2012년 논문 2012年论文 2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված scientific article (publication date: 6 December 2012) 2012年论文 bilimsel makale articolo scientifico artykuł naukowy מאמר מדעי บทความทางวิทยาศาสตร์ 2012年論文 tudományos cikk artículo científico publicado en 2012 2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած научни чланак 2012年论文 2012年論文 vitskapeleg artikkel bài báo khoa học artikulong pang-agham научная статья mokslinis straipsnis articol științific vědecký článek 2012年论文 2012年論文 vitenskapelig artikkel artigo científico სამეცნიერო სტატია vedecký článok مقالة علمية (نشرت في 6-12-2012) videnskabelig artikel vetenskaplig artikel мақолаи илмӣ wetenschappelijk artikel (gepubliceerd op 2012/12/06) tieteellinen artikkeli мақолаи илмӣ
p:P577
wds:Q29615392-E566294E-9A5C-49F9-BFE6-F9D07FD69D39
wdt:P577
2012-12-06T00:00:00Z
p:P407
wds:Q29615392-0E027877-9FCD-4170-AAB2-53E3BCA3D79A
wdt:P407
wd:Q1860
p:P2860
wds:Q29615392-301FE57B-F540-4681-A7AC-AD275D9DC192 wds:Q29615392-580BA888-68CC-4FBC-A9A0-872C0134A7A7 wds:Q29615392-680CF36F-674C-4618-A346-0905D7B708DF wds:Q29615392-3EE1F527-3D3C-47C8-88CB-0759D92BF167 wds:Q29615392-406468B9-E785-45A7-8C9B-5967D4DA9232 wds:Q29615392-48044817-F7DB-49A2-9DB2-2FF633D9CE6A wds:Q29615392-16967659-DA82-4C60-AF02-9D3009A23378 wds:Q29615392-19340059-905B-4262-A2B9-9A855C6BCF4A wds:Q29615392-0C33D383-FEBA-4ACD-8331-B907984BE2BD wds:Q29615392-20B4816F-DDEB-44E8-9AEB-865A59CBCB1A wds:Q29615392-19B37F6F-2241-40BC-8480-1497E65FEB39 wds:Q29615392-1B92B8C0-7247-4833-B283-7A57A0802D7C wds:Q29615392-1CAE9891-8A65-4E93-B140-6C1271BDC2A6 wds:Q29615392-D527D05D-498F-4B95-9530-4FF28ECFC7F4 wds:Q29615392-D8120AC7-A584-4372-A1CB-2E8997FBAC48 wds:Q29615392-D988C7BC-91D7-4B6A-B7FD-9DB89F43CF54 wds:Q29615392-CBAE09BC-9D29-40C4-9FA5-3BC542F88A3B wds:Q29615392-CE7DACC9-C1D2-4D80-B1DA-C05098DE4CDA wds:Q29615392-F0FCCE77-8EF4-469F-A97C-A820615C7D79 wds:Q29615392-DCFC8D64-F094-4BA9-A021-A961675C87B8 wds:Q29615392-796424BC-A8CC-448C-82AE-06F5E3DBE096 wds:Q29615392-6E1BE42C-A808-43E2-A616-915F2B9A7D8E wds:Q29615392-6FA68C4A-689A-47A4-8720-A55F57A75264 wds:Q29615392-7359762D-0CEC-4EE5-8B03-4C76E1BCD947 wds:Q29615392-B6CC8948-83CA-4C8C-A0BC-40CFFA7B9702 wds:Q29615392-B79902BF-8C7E-4F62-8356-D38E86B24687 wds:Q29615392-C1A5FCC9-902F-4EE7-8319-2495C41AE838 wds:Q29615392-9F2A4F14-3780-41B4-9D57-0693DCB0584F wds:Q29615392-A94A2CFD-3898-4884-9B09-4C75CD2D60EA wds:Q29615392-FB2B3A29-D542-4DDD-962B-B0A4D0FC3C17
wdt:P2860
wd:Q27851546 wd:Q42716358 wd:Q33710169 wd:Q52372657 wd:Q24672969 wd:Q41038312 wd:Q35008966 wd:Q29147438 wd:Q29614510 wd:Q33865946 wd:Q84025680 wd:Q24631953 wd:Q33464035 wd:Q27860958 wd:Q41745424 wd:Q29614514 wd:Q34017960 wd:Q21183894 wd:Q34205133 wd:Q84774538 wd:Q37198891 wd:Q34397318 wd:Q28741454 wd:Q37730596 wd:Q27851588 wd:Q35346433 wd:Q39614645 wd:Q39487525 wd:Q24630610 wd:Q29616667
p:P2093
wds:Q29615392-061DE496-0D66-4A04-9B46-6E7DCC7D60F8 wds:Q29615392-1DB647B7-0760-4D0A-9E25-E0D49D8F84A0 wds:Q29615392-25862EC8-2BB2-42C2-BC00-D5FC78D26188 wds:Q29615392-2F4AD051-9D39-4464-BE3A-1AF60872A6C1 wds:Q29615392-2626D87A-676F-4B03-B972-C26944E81085 wds:Q29615392-3583B2DF-7D01-41D7-8800-95985310E3D3 wds:Q29615392-324A3E26-C54E-4425-83B9-7CF5F9B22B43 wds:Q29615392-3613DA13-5346-43CD-A3F1-21E9CBADE66F wds:Q29615392-5A30594D-17FD-464C-9B87-8BB1394F9F55 wds:Q29615392-5614D6B9-2BEE-4E0B-BF07-394165B5995D wds:Q29615392-F5EDCD71-F760-44A0-A282-0E6BA78F2A44 wds:Q29615392-8314A702-85EB-4864-898C-9D398AE1AD2E wds:Q29615392-8997BC9F-3D2A-42E6-B4C2-480ACFEA5659 wds:Q29615392-8F3CEB1F-0A9A-4BC5-BB74-9295A9F30A00 wds:Q29615392-CB0E9863-A7F1-4732-AC4D-2A2A4F79A6F8 wds:Q29615392-D45ED1B3-5297-42F0-8883-51AC79095D9C wds:Q29615392-CBDCF5F4-3C91-4649-802D-D04D60F622BA wds:Q29615392-D54F901E-4F34-4FBB-8985-C79FBC8E9906 wds:Q29615392-D9FCFDFD-B6AD-4829-9E5C-EF6D08D2BAFB wds:Q29615392-DB153777-E258-4DEB-8C6B-5659A380FD96 wds:Q29615392-ECD32ED5-1BDD-4D57-B9D0-4D558A2A16CE wds:Q29615392-E5EE7CA0-B82F-4DA9-9178-78DBFDA732EB
p:P3181
wds:Q29615392-0D94A4C1-B4ED-44CE-8597-10E14A0F1F28
wdtn:P3181
n9:246237
wdt:P2093
Verma SK Creasy CL Kruger RG Dhanak D Ganji G Liu Y Duquenne C Tummino PJ Ott HM Della Pietra A 3rd Thompson C Brandt M LaFrance LV Korenchuk S Miller WH Diaz E McCabe MT McHugh CF Van Aller GS Tian X Mellinger M Graves AP
wdt:P3181
246237
rdfs:label
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
skos:prefLabel
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
schema:name
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
p:P1476
wds:Q29615392-9429974B-A6D4-4C22-9EDD-98D4744BA3D1
wdt:P1476
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
p:P304
wds:Q29615392-2A193CAE-6BC3-495B-B898-92FF843D3A4C
wdt:P304
108-12
p:P31
wds:Q29615392-04B1A707-E7FF-4B0A-8447-68EB5E184AB4
wdt:P31
wd:Q13442814
p:P698
wds:Q29615392-73FCABF6-DCD9-436F-8683-B583422110C9
wdtn:P698
n12:23051747
wdt:P698
23051747
p:P1433
wds:Q29615392-E3D8D011-2333-4B2B-AAB5-FCD4B167F5D0
wdt:P1433
wd:Q180445
p:P433
wds:Q29615392-18D9C4A7-B7D6-4B52-8C21-A3C208AABE93
p:P478
wds:Q29615392-1E4815FC-5E80-490E-AD5E-B5FB1BFF46D1
wdt:P433
7427
wdt:P478
492
p:P356
wds:Q29615392-3516D1D0-4A0F-4E94-B000-9B5840ECAD01
wdtn:P356
n13:NATURE11606
wdt:P356
10.1038/NATURE11606
p:P5875
wds:Q29615392-6B19E441-7539-4EC5-BBEF-F722C5C3A1A3
wdt:P5875
232084582
p:P10863
wds:Q29615392-31B62003-8504-44CF-872E-FDFDA9CA9434
p:P6179
wds:Q29615392-261E8E77-8D45-4B1A-A537-A1A884D96D0B
wdt:P10863
10.1038/nature11606
wdt:P6179
1000463489